Pharmacology of barium nitrosylpentacyanoferrate.
D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology; D001158:Arteries; D001464:Barium / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000633:toxicity*; D001794:Blood Pressure / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects*; D000697:Central Nervous System Stimulants / Q000494:pharmacology; D002560:Cerebrovascular Circulation / Q000187:drug effects; D002712:Chlorides / Q000037:antagonists & inhibitors; D003331:Coronary Vessels / Q000098:blood supply; D003864:Depression, Chemical; D004285:Dogs; D004357:Drug Synergism; D005260:Female; D005292:Ferricyanides / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000494:pharmacology* / Q000633:toxicity*; D006339:Heart Rate / Q000187:drug effects; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D008297:Male; D051379:Mice; D011299:Prenylamine / Q000494:pharmacology; D011427:Propiophenones / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D012039:Regional Blood Flow / Q000187:drug effects; D012964:Sodium / Q000494:pharmacology* / Q000633:toxicity*; D013268:Stimulation, Chemical; D013566:Sympathomimetics / Q000037:antagonists & inhibitors; D014662:Vasoconstrictor Agents / Q000494:pharmacology; D014665:Vasodilator Agents / Q000494:pharmacology
D000959:Antihypertensive Agents; D000697:Central Nervous System Stimulants; D002712:Chlorides; D005292:Ferricyanides; D011427:Propiophenones; D013566:Sympathomimetics; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents; D001464:Barium; D012964:Sodium; D011299:Prenylamine